Query         023650
Match_columns 279
No_of_seqs    122 out of 503
Neff          2.7 
Searched_HMMs 46136
Date          Fri Mar 29 05:36:56 2013
Command       hhsearch -i /work/01045/syshi/csienesis_hhblits_a3m/023650.a3m -d /work/01045/syshi/HHdatabase/Cdd.hhm -o /work/01045/syshi/hhsearch_cdd/023650hhsearch_cdd -cpu 12 -v 0 

 No Hit                             Prob E-value P-value  Score    SS Cols Query HMM  Template HMM
  1 cd04706 PLA2_plant PLA2_plant: 100.0 4.3E-33 9.4E-38  229.0   5.9  112  164-275     1-116 (117)
  2 KOG4087 Phospholipase A2 [Lipi  99.8 9.1E-20   2E-24  155.2   1.8   72  173-248    30-121 (144)
  3 cd00125 PLA2c PLA2c: Phospholi  99.7 1.6E-19 3.5E-24  147.2   0.3   73  173-249    10-101 (115)
  4 cd04707 otoconin_90 otoconin_9  99.7 5.3E-19 1.1E-23  145.2   1.1   71  173-248     7-97  (117)
  5 smart00085 PA2c Phospholipase   99.6 3.5E-17 7.6E-22  132.9   0.2   73  173-249    10-102 (117)
  6 cd00618 PLA2_like PLA2_like: P  99.6 1.2E-15 2.6E-20  113.8   2.0   65  184-248     1-82  (83)
  7 PF00068 Phospholip_A2_1:  Phos  99.5 1.1E-15 2.4E-20  123.2  -1.5   76  173-254    10-105 (116)
  8 cd04704 PLA2_bee_venom_like PL  98.6 1.2E-08 2.7E-13   81.5   1.6   50  188-240     7-76  (97)
  9 PF05826 Phospholip_A2_2:  Phos  98.2 2.5E-07 5.3E-12   74.0  -0.5   51  188-238     6-73  (99)
 10 PF08398 Parvo_coat_N:  Parvovi  96.8 0.00065 1.4E-08   52.0   1.7   32  188-220     5-36  (64)
 11 cd04705 PLA2_group_III_like PL  96.4  0.0012 2.6E-08   53.9   1.1   36  205-240    33-83  (100)
 12 PF06951 PLA2G12:  Group XII se  96.2  0.0046   1E-07   55.2   3.7   73  166-238    54-130 (184)
 13 PF10690 Myticin-prepro:  Mytic  37.8     3.7   8E-05   34.1  -2.7   43  148-190     7-53  (98)
 14 PF12431 CitT:  Transcriptional  22.0      35 0.00076   22.4   0.3    7   88-94     21-27  (30)
 15 PF14831 DUF4484:  Domain of un  21.9      72  0.0016   28.7   2.4   19    9-27     61-79  (176)
 16 PF01186 Lysyl_oxidase:  Lysyl   21.3      27 0.00058   32.3  -0.5   16   49-65     78-93  (205)

No 1  
>cd04706 PLA2_plant PLA2_plant: Plant-specific sub-family of  Phospholipase A2, a super-family of secretory and cytosolic enzymes; the latter are either Ca dependent or Ca independent. Enzymatically active PLA2 cleaves the sn-2 position of the glycerol backbone of phospholipids; secreted PLA2s have also been found to specifically bind to a variety of soluble and membrane proteins in mammals, including receptors. As a toxin, PLA2 is a potent presynaptic neurotoxin which blocks nerve terminals by binding to the nerve membrane and hydrolyzing stable membrane lipids. The products of the hydrolysis cannot form bilayers leading to a change in membrane conformation and ultimately to a block in the release of neurotransmitters. PLA2 may form dimers or oligomers. This sub-family does not appear to have a conserved active site and metal-binding loop.
Probab=99.98  E-value=4.3e-33  Score=229.03  Aligned_cols=112  Identities=44%  Similarity=0.929  Sum_probs=105.2

Q ss_pred             cCCccccccccccccCCcc-cCCCCcCccCCCCCCCCCCCCChhhhhhhhccchhhh--cCCcccccccchHHHHHHhcc
Q 023650          164 NDSQVKCSRTCVAENCNSV-GIRYGKYCGVGWSGCPGEKPCDDLDACCKIHDECVDK--KGLTNIKCHEKFKRCIKKVQK  240 (279)
Q Consensus       164 ~s~~~~CSr~C~s~~C~~~-y~~YGCYCG~GgsG~pGe~PVD~LD~CC~~HD~CY~~--~~~~nctCD~kf~~Clk~IDK  240 (279)
                      ++.++.|||+|++.+|+.+ |..||||||+|++|.||+.|+|+||+||+.||.||++  .++.+++|+.+|.+|+.++++
T Consensus         1 ~~~~~~csrtc~~~~c~~~~y~~YG~yCG~g~~g~~~~~P~D~lD~CC~~HD~Cy~~~~~~~~~c~C~~~f~~Cl~~~~~   80 (117)
T cd04706           1 ISVPEECSRTCESYFCSGPPFLRYGKYCGPGYSGCPGERPCDDLDACCMTHDACVQAKKNDYLSLECNEKFKNCVRRFRK   80 (117)
T ss_pred             CCccccccccchhhhccCCcccccCcccCCCCCCCCCCCCcchhhHHHHhCcCcccCCCCCcCCchHHHHHHHHHHHhcc
Confidence            3578999999999999988 9999999999999989999999999999999999998  678999999999999999988


Q ss_pred             c-cCcccCCCCCccccchhhhccchhhhhhcccCCC
Q 023650          241 S-AKVGFSRECPYDTVVPTMVQGMDMAILLSQLGGS  275 (279)
Q Consensus       241 s-aA~CFsrkCp~~~vi~tm~~GMd~AiL~s~l~~~  275 (279)
                      + ++..|+++|+++.++|+|..+||+|+|||+++..
T Consensus        81 ~~~~~~~~~~C~~~~v~~~i~~~~~~a~~~~~~~~~  116 (117)
T cd04706          81 ARKPTFEGNKCIVTFVIPVITVVMDAALIASKLGKR  116 (117)
T ss_pred             cccceeccccCccceeeeeeecchHHHHHHHHhccC
Confidence            7 7888899999999999999999999999998864


No 2  
>KOG4087 consensus Phospholipase A2 [Lipid transport and metabolism]
Probab=99.77  E-value=9.1e-20  Score=155.18  Aligned_cols=72  Identities=36%  Similarity=0.720  Sum_probs=65.1

Q ss_pred             ccccccCCc-ccCCCCcCccCCCCCCCCCCCCChhhhhhhhccchhhhcC----------------CcccccccchHHHH
Q 023650          173 TCVAENCNS-VGIRYGKYCGVGWSGCPGEKPCDDLDACCKIHDECVDKKG----------------LTNIKCHEKFKRCI  235 (279)
Q Consensus       173 ~C~s~~C~~-~y~~YGCYCG~GgsG~pGe~PVD~LD~CC~~HD~CY~~~~----------------~~nctCD~kf~~Cl  235 (279)
                      +|+++.-+. .|+.||||||.||+|.    |+|+|||||+.||+||+++.                +.+++|++++..|+
T Consensus        30 ~~vt~~~~~l~Y~~YGCyCGlGG~G~----P~D~iDwCC~~HDcCY~~le~~gC~py~~~Ys~sc~n~~I~Cs~~~~~C~  105 (144)
T KOG4087|consen   30 ECVTGKSAALSYNKYGCYCGLGGSGQ----PKDAIDWCCHAHDCCYDRLEEKGCSPYTERYSWSCSNQSITCSDKNTECE  105 (144)
T ss_pred             HHHcCCCccceecCccccccCCCCCC----ccchHHHHHhcccHHHHHHHHcCCCccccceeeEeeCCeEEeCCCccHHH
Confidence            677777744 4999999999999999    99999999999999999874                36899999999999


Q ss_pred             HHh---ccccCcccCC
Q 023650          236 KKV---QKSAKVGFSR  248 (279)
Q Consensus       236 k~I---DKsaA~CFsr  248 (279)
                      +.+   ||.+++||++
T Consensus       106 ~~lC~CDk~~a~C~~r  121 (144)
T KOG4087|consen  106 AQLCECDKKAAECLKR  121 (144)
T ss_pred             HHHhhhhhHHHHHHhc
Confidence            999   9999999987


No 3  
>cd00125 PLA2c PLA2c: Phospholipase A2, a family of secretory and cytosolic enzymes; the latter are either Ca dependent or Ca independent. PLA2 cleaves the sn-2 position of the glycerol backbone of phospholipids (PC or phosphatidylethanolamine), usually in a metal-dependent reaction, to generate lysophospholipid (LysoPL) and a free fatty acid (FA). The resulting products are either dietary or used in synthetic pathways for leukotrienes and prostaglandins. Often, arachidonic acid is released as a free fatty acid and acts as second messenger in signaling networks. Secreted PLA2s have also been found to specifically bind to a variety of soluble and membrane proteins in mammals, including receptors. As a toxin, PLA2 is a potent presynaptic neurotoxin which blocks nerve terminals by binding to the nerve membrane and hydrolyzing stable membrane lipids. The products of the hydrolysis (LysoPL and FA) cannot form bilayers leading to a change in membrane conformation and ultimately to a block in 
Probab=99.75  E-value=1.6e-19  Score=147.25  Aligned_cols=73  Identities=34%  Similarity=0.767  Sum_probs=65.1

Q ss_pred             ccccccCCcccCCCCcCccCCCCCCCCCCCCChhhhhhhhccchhhhcC----------------CcccccccchHHHHH
Q 023650          173 TCVAENCNSVGIRYGKYCGVGWSGCPGEKPCDDLDACCKIHDECVDKKG----------------LTNIKCHEKFKRCIK  236 (279)
Q Consensus       173 ~C~s~~C~~~y~~YGCYCG~GgsG~pGe~PVD~LD~CC~~HD~CY~~~~----------------~~nctCD~kf~~Clk  236 (279)
                      +|++++.+..|++||||||+|++|.    |||+||+||+.||.||+++.                ...++|+.....|.+
T Consensus        10 ~c~tgr~~~~Y~~YGCyCG~GG~G~----PvD~~DrCC~~HD~CY~~~~~~~C~p~~~~Y~y~~~~~~i~C~~~~~~C~~   85 (115)
T cd00125          10 KCTTGRSALDYNGYGCYCGLGGSGT----PVDDTDRCCQVHDCCYDRAEKGGCSPYFTSYSYTCSDGQITCSDANDKCAR   85 (115)
T ss_pred             HHhcCCCHHHHhhcCCccCCCCCCC----CcccHHHHHHHHHhHHhccccCCCccccccceEEEECCcceECcCCChHhH
Confidence            5778877778999999999999998    99999999999999999873                257899888789999


Q ss_pred             Hh---ccccCcccCCC
Q 023650          237 KV---QKSAKVGFSRE  249 (279)
Q Consensus       237 ~I---DKsaA~CFsrk  249 (279)
                      .+   |+++|+||+++
T Consensus        86 ~~CeCDr~aa~Cf~~~  101 (115)
T cd00125          86 ALCECDRAAALCFARA  101 (115)
T ss_pred             HHhHccHHHHHHHhhC
Confidence            99   99999999864


No 4  
>cd04707 otoconin_90 otoconin_90: Phospholipase A2-like domains present in otoconin-90 and otoconin-95, mammal proteins that are principal matrix proteins of calcitic otoconia. Interactions involving otoconin-90 may trigger or constitute key events in otoconia formation. The PLA2-like domains in otoconins may have lost their metal-binding sites.
Probab=99.73  E-value=5.3e-19  Score=145.17  Aligned_cols=71  Identities=31%  Similarity=0.634  Sum_probs=60.4

Q ss_pred             ccccccCCcccCCCCcCccCCCCCCCCCCCCChhhhhhhhccchhhhcC-----------------CcccccccchHHHH
Q 023650          173 TCVAENCNSVGIRYGKYCGVGWSGCPGEKPCDDLDACCKIHDECVDKKG-----------------LTNIKCHEKFKRCI  235 (279)
Q Consensus       173 ~C~s~~C~~~y~~YGCYCG~GgsG~pGe~PVD~LD~CC~~HD~CY~~~~-----------------~~nctCD~kf~~Cl  235 (279)
                      +|++++....|++||||||+|++|.    |||+|||||+.||+||++++                 ..+++|+ ....|.
T Consensus         7 ~c~tgr~~~~Y~~YGCyCG~GG~G~----PvD~~DrCC~~HD~CY~~~~~~~C~~~~~~~Y~y~c~~~~i~C~-~~~~C~   81 (117)
T cd04707           7 KCLTGRCPREFEDYGCYCGQEGEGL----PVDELDRCCFQHRCCLEQASEMGCLQDRKLSTEVTCVDHKPKCE-GVSVCE   81 (117)
T ss_pred             hhhcCCCHHHHcccCCcccCCCCCC----CcccchhHHHHhHHHHhhhhhcCCCCCCCcceEEEEECCccccC-CCChHH
Confidence            5667777777999999999999998    99999999999999999763                 1356774 445699


Q ss_pred             HHh---ccccCcccCC
Q 023650          236 KKV---QKSAKVGFSR  248 (279)
Q Consensus       236 k~I---DKsaA~CFsr  248 (279)
                      +.+   |+++|+||++
T Consensus        82 ~~vCeCDk~aa~Cf~~   97 (117)
T cd04707          82 KLLCTCDKTAAECMAA   97 (117)
T ss_pred             HHHhhccHHHHHHhcc
Confidence            999   9999999986


No 5  
>smart00085 PA2c Phospholipase A2.
Probab=99.63  E-value=3.5e-17  Score=132.87  Aligned_cols=73  Identities=32%  Similarity=0.629  Sum_probs=56.0

Q ss_pred             ccccccCCc-ccCCCCcCccCCCCCCCCCCCCChhhhhhhhccchhhhcC---------Ccccccccc-------hHHHH
Q 023650          173 TCVAENCNS-VGIRYGKYCGVGWSGCPGEKPCDDLDACCKIHDECVDKKG---------LTNIKCHEK-------FKRCI  235 (279)
Q Consensus       173 ~C~s~~C~~-~y~~YGCYCG~GgsG~pGe~PVD~LD~CC~~HD~CY~~~~---------~~nctCD~k-------f~~Cl  235 (279)
                      +|+++..+. .|..||||||+|++|.    |+|+||+||+.||.||+++.         ..+++|+++       ...|.
T Consensus        10 ~c~t~~~~~~~y~~YGCyCG~gg~G~----pvD~~D~CC~~HD~Cy~~~~~~~C~~~~~~y~~~c~~~~~~C~~~~~~C~   85 (117)
T smart00085       10 QCATGKRAWLSYGDYGCYCGWGGSGT----PVDATDRCCFVHDCCYGKAEKEGCNPKTTTYSYSCDNGFITCGGKNTACL   85 (117)
T ss_pred             HHhcCCCcccchhccCcccCCCCCCC----ccccccchhhhcCchhhhcccCCCcccccceEEEEECCcceECcCCCccc
Confidence            577775443 4999999999999998    99999999999999999763         123444444       44555


Q ss_pred             HHh---ccccCcccCCC
Q 023650          236 KKV---QKSAKVGFSRE  249 (279)
Q Consensus       236 k~I---DKsaA~CFsrk  249 (279)
                      ..+   |+.+++||+++
T Consensus        86 ~~~C~CD~~aa~Cf~~~  102 (117)
T smart00085       86 VFVCECDRAAAICFAKN  102 (117)
T ss_pred             eeecccCHHHHHHhhhC
Confidence            555   88899999854


No 6  
>cd00618 PLA2_like PLA2_like: Phospholipase A2, a super-family of secretory and cytosolic enzymes; the latter are either Ca dependent or Ca independent. PLA2 cleaves the sn-2 position of the glycerol backbone of phospholipids (PC or phosphatidylethanolamine), usually in a metal-dependent reaction, to generate lysophospholipid (LysoPL) and a free fatty acid (FA). The resulting products are either dietary or used in synthetic pathways for leukotrienes and prostaglandins. Often, arachidonic acid is released as a free fatty acid and acts as second messenger in signaling networks. Secreted PLA2s have also been found to specifically bind to a variety of soluble and membrane proteins in mammals, including receptors. As a toxin, PLA2 is a potent presynaptic neurotoxin which blocks nerve terminals by binding to the nerve membrane and hydrolyzing stable membrane lipids. The products of the hydrolysis (LysoPL and FA) cannot form bilayers leading to a change in membrane conformation and ultimately 
Probab=99.55  E-value=1.2e-15  Score=113.80  Aligned_cols=65  Identities=32%  Similarity=0.789  Sum_probs=49.5

Q ss_pred             CCCCcCccCCCCCCCCCCCCChhhhhhhhccchhhhcCC--------------cccccccchHHHHHHh---ccccCccc
Q 023650          184 IRYGKYCGVGWSGCPGEKPCDDLDACCKIHDECVDKKGL--------------TNIKCHEKFKRCIKKV---QKSAKVGF  246 (279)
Q Consensus       184 ~~YGCYCG~GgsG~pGe~PVD~LD~CC~~HD~CY~~~~~--------------~nctCD~kf~~Clk~I---DKsaA~CF  246 (279)
                      +.||||||+|+++.+++.|+|+||+||+.||.||+.+..              ..++|..+...|...+   |+.++.||
T Consensus         1 ~~ygc~CG~g~~~~~~g~p~D~~D~CC~~HD~Cy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~c~~~~C~CD~~~a~Cl   80 (83)
T cd00618           1 LPYGCYCGPGGSACPSGQPVDETDRCCRKHDCCYDQISDGGCCDGCLSYSFSEGGVTCLTNSDLCTRSHCDCDRRLAICL   80 (83)
T ss_pred             CCcCcccCCCCcCCCCCCCCCcchhhhhhCccHhhhhhccCCCCCcceeeecCCceeECCCCChhhHhhCcccHHHHHHh
Confidence            479999999999777777999999999999999998742              1233445556676666   66777777


Q ss_pred             CC
Q 023650          247 SR  248 (279)
Q Consensus       247 sr  248 (279)
                      ++
T Consensus        81 ~~   82 (83)
T cd00618          81 AR   82 (83)
T ss_pred             hh
Confidence            53


No 7  
>PF00068 Phospholip_A2_1:  Phospholipase A2;  InterPro: IPR001211 Phospholipase A2 (3.1.1.4 from EC) (PLA2) is a small lipolytic enzyme that releases fatty acids from the second carbon group of glycerol. It is involved in a number of physiologically important cellular processes, such as the liberation of arachidonic acid from membrane phospholipids []. It plays a pivotal role in the biosynthesis of prostaglandin and other mediators of inflammation. PLA2 has four to seven disulphide bonds and binds a calcium ion that is essential for activity. Within the active enzyme, the alpha amino group is involved in a conserved hydrogen-bonding network linking the N-terminal region to the active site. The side chains of two conserved residues, His and Asp, participate in the catalytic network. Many PLA2's are widely distributed in snakes, lizards, bees and mammals. In mammals there are at least four forms: pancreatic, membrane-associated as well as two less well characterised forms. The venom of most snakes contains multiple forms of PLA2. Some of them are presynaptic neurotoxins which inhibit neuromuscular transmission by blocking acetylcholine release from the nerve termini. Some of the proteins in this family are allergens. Allergies are hypersensitivity reactions of the immune system to specific substances called allergens (such as pollen, stings, drugs, or food) that, in most people, result in no symptoms. A nomenclature system has been established for antigens (allergens) that cause IgE-mediated atopic allergies in humans [WHO/IUIS Allergen Nomenclature Subcommittee King T.P., Hoffmann D., Loewenstein H., Marsh D.G., Platts-Mills T.A.E., Thomas W. Bull. World Health Organ. 72:797-806(1994)]. This nomenclature system is defined by a designation that is composed of the first three letters of the genus; a space; the first letter of the species name; a space and an arabic number. In the event that two species names have identical designations, they are discriminated from one another by adding one or more letters (as necessary) to each species designation.  The allergens in this family include allergens with the following designations: Api m 1.; GO: 0004623 phospholipase A2 activity, 0005509 calcium ion binding, 0016042 lipid catabolic process; PDB: 1OQS_F 1S6B_B 1XXW_B 1MH2_B 2RD4_B 1OZ6_A 2OSN_A 2PH4_B 1FDK_A 2BP2_A ....
Probab=99.51  E-value=1.1e-15  Score=123.23  Aligned_cols=76  Identities=32%  Similarity=0.694  Sum_probs=61.6

Q ss_pred             ccccccCCc-ccCCCCcCccCCCCCCCCCCCCChhhhhhhhccchhhhcC----------------CcccccccchHHHH
Q 023650          173 TCVAENCNS-VGIRYGKYCGVGWSGCPGEKPCDDLDACCKIHDECVDKKG----------------LTNIKCHEKFKRCI  235 (279)
Q Consensus       173 ~C~s~~C~~-~y~~YGCYCG~GgsG~pGe~PVD~LD~CC~~HD~CY~~~~----------------~~nctCD~kf~~Cl  235 (279)
                      +|+++..+. .|.+||||||+|+.|.    |||+||+||+.||.||+.+.                ..+++|++ ..+|.
T Consensus        10 ~~~~~~~~~~~y~~YGCyCg~~g~G~----PvD~iD~~C~~h~~Cy~~~~~~~C~~~~~~Y~~~~~~~~i~C~~-~~~C~   84 (116)
T PF00068_consen   10 KCVTGKFPFFKYNDYGCYCGFGGKGQ----PVDEIDRCCRKHDQCYKCAKEKGCDPYFTSYSYSCSNKNITCSD-NDSCE   84 (116)
T ss_dssp             HHHHSSSHHHHHSSBTTTBSSSSSSS-----SSHHHHHHHHHHHHHHHHTTTTSSTTTSS-EEEEETTEEEEES-SSHHH
T ss_pred             HHhhCCCcHHHHccccccCCCCCCCC----CcccccchhHHhHHHHHHHhcccccccccceEEEEecCCcccCC-CCchh
Confidence            455555543 4999999999999998    99999999999999999874                24689988 88999


Q ss_pred             HHh---ccccCcccCCCCCccc
Q 023650          236 KKV---QKSAKVGFSRECPYDT  254 (279)
Q Consensus       236 k~I---DKsaA~CFsrkCp~~~  254 (279)
                      +.+   |++.|.||++. +|+.
T Consensus        85 ~~lCeCD~~~A~cl~~~-~yn~  105 (116)
T PF00068_consen   85 RALCECDKAFAECLARN-SYNK  105 (116)
T ss_dssp             HHHHHHHHHHHHHHHHT-GB-G
T ss_pred             HHhhhCcHHHHHHHHhC-ccCH
Confidence            999   99999999765 4443


No 8  
>cd04704 PLA2_bee_venom_like PLA2_bee_venom_like: A sub-family of  Phospholipase A2, similar to bee venom PLA2. PLA2 is a super-family of secretory and cytosolic enzymes; the latter are either Ca dependent or Ca independent. Enzymatically active PLA2 cleaves the sn-2 position of the glycerol backbone of phospholipids; secreted PLA2s have also been found to specifically bind to a variety of soluble and membrane proteins in mammals, including receptors. As a toxin, PLA2 is a potent presynaptic neurotoxin which blocks nerve terminals by binding to the nerve membrane and hydrolyzing stable membrane lipids. The products of the hydrolysis cannot form bilayers leading to a change in membrane conformation and ultimately to a block in the release of neurotransmitters. PLA2 may form dimers or oligomers. Bee venom PLA2 has fewer conserved disulfide bridges than most canonical PLA2s.
Probab=98.62  E-value=1.2e-08  Score=81.52  Aligned_cols=50  Identities=32%  Similarity=0.803  Sum_probs=41.8

Q ss_pred             cCccCCCCCCCCCCCC-----ChhhhhhhhccchhhhcC---------------CcccccccchHHHHHHhcc
Q 023650          188 KYCGVGWSGCPGEKPC-----DDLDACCKIHDECVDKKG---------------LTNIKCHEKFKRCIKKVQK  240 (279)
Q Consensus       188 CYCG~GgsG~pGe~PV-----D~LD~CC~~HD~CY~~~~---------------~~nctCD~kf~~Clk~IDK  240 (279)
                      +|||+|..+..   +.     ..+|+||+.||.|++...               ..+|.||.+|.+|++.+..
T Consensus         7 kWCG~Gn~a~~---~~dlG~~~~tD~CCr~HD~C~~~i~~~~~kyg~~N~~~~t~~~C~CD~~f~~CL~~~~~   76 (97)
T cd04704           7 KWCGPGNIATN---YSDLGAFRETDKCCREHDHCPDIISAGEYKYGLTNTRLFTRSHCDCDNRFRQCLKNVND   76 (97)
T ss_pred             eecCCCCCCCC---cccccCccccchHHHccccCcCcccccccccCccCCCccccccCcHHHHHHHHHHHcCC
Confidence            89999998751   33     589999999999998642               3689999999999998854


No 9  
>PF05826 Phospholip_A2_2:  Phospholipase A2;  InterPro: IPR001211 Phospholipase A2 (3.1.1.4 from EC) (PLA2) is a small lipolytic enzyme that releases fatty acids from the second carbon group of glycerol. It is involved in a number of physiologically important cellular processes, such as the liberation of arachidonic acid from membrane phospholipids []. It plays a pivotal role in the biosynthesis of prostaglandin and other mediators of inflammation. PLA2 has four to seven disulphide bonds and binds a calcium ion that is essential for activity. Within the active enzyme, the alpha amino group is involved in a conserved hydrogen-bonding network linking the N-terminal region to the active site. The side chains of two conserved residues, His and Asp, participate in the catalytic network. Many PLA2's are widely distributed in snakes, lizards, bees and mammals. In mammals there are at least four forms: pancreatic, membrane-associated as well as two less well characterised forms. The venom of most snakes contains multiple forms of PLA2. Some of them are presynaptic neurotoxins which inhibit neuromuscular transmission by blocking acetylcholine release from the nerve termini. Some of the proteins in this family are allergens. Allergies are hypersensitivity reactions of the immune system to specific substances called allergens (such as pollen, stings, drugs, or food) that, in most people, result in no symptoms. A nomenclature system has been established for antigens (allergens) that cause IgE-mediated atopic allergies in humans [WHO/IUIS Allergen Nomenclature Subcommittee King T.P., Hoffmann D., Loewenstein H., Marsh D.G., Platts-Mills T.A.E., Thomas W. Bull. World Health Organ. 72:797-806(1994)]. This nomenclature system is defined by a designation that is composed of the first three letters of the genus; a space; the first letter of the species name; a space and an arabic number. In the event that two species names have identical designations, they are discriminated from one another by adding one or more letters (as necessary) to each species designation.  The allergens in this family include allergens with the following designations: Api m 1.; GO: 0004623 phospholipase A2 activity, 0005509 calcium ion binding, 0016042 lipid catabolic process; PDB: 1POC_A.
Probab=98.19  E-value=2.5e-07  Score=74.01  Aligned_cols=51  Identities=33%  Similarity=0.766  Sum_probs=36.4

Q ss_pred             cCccCCCCCCCCC--CCCChhhhhhhhccchhhhcC---------------CcccccccchHHHHHHh
Q 023650          188 KYCGVGWSGCPGE--KPCDDLDACCKIHDECVDKKG---------------LTNIKCHEKFKRCIKKV  238 (279)
Q Consensus       188 CYCG~GgsG~pGe--~PVD~LD~CC~~HD~CY~~~~---------------~~nctCD~kf~~Clk~I  238 (279)
                      +|||+|.......  -.--.+|+||+.||.|.....               ..+|.||.+|.+|++.+
T Consensus         6 ~WCG~gn~a~~~~dlG~~~~tD~CCR~HD~C~~~I~~~~~k~gl~N~~~~T~~hC~Cd~~f~~CL~~~   73 (99)
T PF05826_consen    6 KWCGPGNIAKNYSDLGEFKETDRCCREHDHCPDKIPPGETKYGLHNPRPFTISHCDCDSRFYQCLKNV   73 (99)
T ss_dssp             SSSBSS---SSTT---SSHHHHHHHHHHHT-SSEE-TT-EETTEE--SSS-EEBHHHHHHHHHHHHTS
T ss_pred             cccCCCCCccCcccccccHHHHHHHHhhccCCCccCCCccccccccCCcCceeecCcccHHHHHHHHc
Confidence            8999998765200  012389999999999998753               36899999999999886


No 10 
>PF08398 Parvo_coat_N:  Parvovirus coat protein VP1;  InterPro: IPR013607 Parvoviruses are some of the smallest viruses containing linear, non-segmented single-stranded DNA genomes, with an average genome size of 5000 nucleotides. Parvoviruses have been described that infect a wide range of invertebrates and vertebrates and are well known for causing enteric disease in mammals. Genomes contains two large ORFs: NS1 and VP1; other ORFs are found in some sub-types and different gene products can arise from splice variants and the use of different start codons [].  This is the N-terminal region of the Parvovirus VP1 coat protein []; its function is not known. ; GO: 0005198 structural molecule activity, 0019028 viral capsid
Probab=96.79  E-value=0.00065  Score=52.04  Aligned_cols=32  Identities=38%  Similarity=0.558  Sum_probs=28.8

Q ss_pred             cCccCCCCCCCCCCCCChhhhhhhhccchhhhc
Q 023650          188 KYCGVGWSGCPGEKPCDDLDACCKIHDECVDKK  220 (279)
Q Consensus       188 CYCG~GgsG~pGe~PVD~LD~CC~~HD~CY~~~  220 (279)
                      +|+|||+.-..| .|++.+|+.++.||..|++.
T Consensus         5 ~YlGPgn~l~~g-~Pv~~~D~aA~~HD~aY~~~   36 (64)
T PF08398_consen    5 KYLGPGNPLDNG-EPVNPVDAAAREHDEAYDEL   36 (64)
T ss_pred             CccCCCCCcCCC-CCCCHHHHHHHHHHHHHHHH
Confidence            799999987666 49999999999999999985


No 11 
>cd04705 PLA2_group_III_like PLA2_group_III_like: A sub-family of  Phospholipase A2, similar to human group III PLA2. PLA2 is a super-family of secretory and cytosolic enzymes; the latter are either Ca dependent or Ca independent. Enzymatically active PLA2 cleaves the sn-2 position of the glycerol backbone of phospholipids; secreted PLA2s have also been found to specifically bind to a variety of soluble and membrane proteins in mammals, including receptors. As a toxin, PLA2 is a potent presynaptic neurotoxin which blocks nerve terminals by binding to the nerve membrane and hydrolyzing stable membrane lipids. The products of the hydrolysis cannot form bilayers leading to a change in membrane conformation and ultimately to a block in the release of neurotransmitters. PLA2 may form dimers or oligomers.
Probab=96.43  E-value=0.0012  Score=53.95  Aligned_cols=36  Identities=22%  Similarity=0.664  Sum_probs=31.1

Q ss_pred             hhhhhhhhccchhhhcC---------------CcccccccchHHHHHHhcc
Q 023650          205 DLDACCKIHDECVDKKG---------------LTNIKCHEKFKRCIKKVQK  240 (279)
Q Consensus       205 ~LD~CC~~HD~CY~~~~---------------~~nctCD~kf~~Clk~IDK  240 (279)
                      .+|+||+.||.|-....               ..+|.||..|.+|++.+..
T Consensus        33 ~~DrCCR~HD~Cp~~I~~~~~k~gl~N~~~~tisHCdCD~rf~~CL~~~n~   83 (100)
T cd04705          33 EPDRCCWKHKQCPGHIIPPFSSDGHHNFHLHSVSHCDCDSRLKDCLRLSSS   83 (100)
T ss_pred             chhhhhhhhhcCccccCCcccccceecCCCcccccccHHHHHHHHHHHcCC
Confidence            68999999999998753               2689999999999998844


No 12 
>PF06951 PLA2G12:  Group XII secretory phospholipase A2 precursor (PLA2G12);  InterPro: IPR010711 This family consists of several group XII secretory phospholipase A2 precursor (PLA2G12) (3.1.1.4 from EC) proteins. Group XII and group V PLA(2)s are thought to participate in helper T cell immune response through release of immediate second signals and generation of downstream eicosanoids [].; GO: 0004623 phospholipase A2 activity, 0005509 calcium ion binding, 0016042 lipid catabolic process, 0005576 extracellular region
Probab=96.22  E-value=0.0046  Score=55.23  Aligned_cols=73  Identities=25%  Similarity=0.510  Sum_probs=53.4

Q ss_pred             CccccccccccccCCcccCCC----CcCccCCCCCCCCCCCCChhhhhhhhccchhhhcCCcccccccchHHHHHHh
Q 023650          166 SQVKCSRTCVAENCNSVGIRY----GKYCGVGWSGCPGEKPCDDLDACCKIHDECVDKKGLTNIKCHEKFKRCIKKV  238 (279)
Q Consensus       166 ~~~~CSr~C~s~~C~~~y~~Y----GCYCG~GgsG~pGe~PVD~LD~CC~~HD~CY~~~~~~nctCD~kf~~Clk~I  238 (279)
                      ....|.++|-.+..+.+.+.|    =+=||.-.-|-+-...+-..-.||-.||.||+.=+...-.||.+|.+|+.++
T Consensus        54 ~d~~C~y~Cp~G~~p~pr~g~k~p~~NGCGS~~~G~~~d~~iP~~t~CCn~HDiCYdTCg~~K~~CD~~F~~CL~~~  130 (184)
T PF06951_consen   54 KDGVCQYRCPYGQKPVPRPGYKPPEPNGCGSYFLGLQIDIGIPAMTKCCNQHDICYDTCGSSKEDCDSQFKSCLEKI  130 (184)
T ss_pred             CCCCceeeCCCCCCCCCCCCCCCCCCCCCCCcccCCcccCCCCchhccchhhhhHHHccCCCHHHHHHHHHHHHHHH
Confidence            567899999999987754444    2668874334310011213678999999999998878889999999999998


No 13 
>PF10690 Myticin-prepro:  Myticin pre-proprotein from the mussel;  InterPro: IPR019631  Myticin is a cysteine-rich peptide produced in three isoforms, A, B and C, by Mytilus galloprovincialis (Mediterranean mussel). Isoforms A and B show antibacterial activity against Gram-positive bacteria, while isoform B is additionally active against the fungus Fusarium oxysporum and a Gram-negative bacterium, Escherichia coli (streptomycin resistant strain D31) []. Myticin-prepro is the precursor peptide. The mature molecule, named myticin, consists of 40 residues, with four intramolecular disulphide bridges and a cysteine array in the primary structure different from that of previously characterised cysteine-rich antimicrobial peptides. The first 20 amino acids are a putative signal peptide, and the antimicrobial peptide sequence is a 36-residue C-terminal extension. Such a structure suggests that myticins are synthesised as prepro-proteins that are then processed by various proteolytic events before storage in the haemocytes as the active peptide. Myticin precursors are expressed mainly in the haemocytes. ; PDB: 2EEM_A.
Probab=37.79  E-value=3.7  Score=34.14  Aligned_cols=43  Identities=19%  Similarity=0.450  Sum_probs=16.4

Q ss_pred             HHHHHHHHHhhhcccccCCccc-cccccccccCCcc---cCCCCcCc
Q 023650          148 FAFVFIIVFSESASALNDSQVK-CSRTCVAENCNSV---GIRYGKYC  190 (279)
Q Consensus       148 ~~~~~~~l~~~a~~a~~s~~~~-CSr~C~s~~C~~~---y~~YGCYC  190 (279)
                      ||+++-.+.++..+.+++.--. |++.|-+..|..+   ..+.||||
T Consensus         7 LAv~vAViv~v~ea~s~~CtS~yC~~fCgsa~C~~Y~c~~l~~gk~C   53 (98)
T PF10690_consen    7 LAVVVAVIVGVQEAQSISCTSYYCKKFCGSARCSLYGCYSLHPGKIC   53 (98)
T ss_dssp             ------------------HHHH-HHHHHHHTT-SEEEEEEETTEEEE
T ss_pred             cccccccccccccccccccchhHHHHhcCCCCCcEEEEEEECCCeEE
Confidence            4444444455666666554444 8999999999875   23555554


No 14 
>PF12431 CitT:  Transcriptional regulator 
Probab=22.02  E-value=35  Score=22.39  Aligned_cols=7  Identities=71%  Similarity=1.066  Sum_probs=5.7

Q ss_pred             eecCCce
Q 023650           88 LSLPKGI   94 (279)
Q Consensus        88 ~~~~~~~   94 (279)
                      -.|||||
T Consensus        21 ~~LPKGI   27 (30)
T PF12431_consen   21 ERLPKGI   27 (30)
T ss_pred             cCCCCCc
Confidence            4599998


No 15 
>PF14831 DUF4484:  Domain of unknown function (DUF4484)
Probab=21.93  E-value=72  Score=28.65  Aligned_cols=19  Identities=42%  Similarity=0.800  Sum_probs=15.6

Q ss_pred             hhhhhHHHHHHHHHHHHHh
Q 023650            9 QRIKVAIILYFHLLERLLI   27 (279)
Q Consensus         9 ~~~~~~~~~~~~~~~~~~~   27 (279)
                      +++-++||-|||-|-..+.
T Consensus        61 ~~~eiaiVaYFHrlTt~if   79 (176)
T PF14831_consen   61 ARIEIAIVAYFHRLTTQIF   79 (176)
T ss_pred             HHHHHHHHHHHHHHHHHHH
Confidence            6788999999998876554


No 16 
>PF01186 Lysyl_oxidase:  Lysyl oxidase ;  InterPro: IPR001695 Lysyl oxidase (1.4.3.13 from EC) (LOX) [] is an extracellular copper-dependent enzyme that catalyses the oxidative deamination of peptidyl lysine residues in precursors of various collagens and elastins, yielding alpha-aminoadipic-delta-semialdehyde. The deaminated lysines are then able to form semialdehyde cross-links, resulting in the formation of insoluble collagen and elastin fibres in the extracellular matrix []. The active site of LOX resides towards the C terminus: this region also binds a single copper atom in an octahedral coordination complex involving at least 3 His residues []. Four histidine residues are clustered in a central region of the enzyme. This region is thought to be involved in cooper-binding and is called the 'copper-talon' [].; GO: 0005507 copper ion binding, 0016641 oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor, 0055114 oxidation-reduction process
Probab=21.27  E-value=27  Score=32.27  Aligned_cols=16  Identities=44%  Similarity=1.084  Sum_probs=12.4

Q ss_pred             ccchhhcccccchhhhh
Q 023650           49 RCHVAHWHSLDRFSLFR   65 (279)
Q Consensus        49 ~~~~~~~~~~~~~~~~~   65 (279)
                      .|| .||||+|-|+-|.
T Consensus        78 ~cH-~HyHsmd~Fa~Yd   93 (205)
T PF01186_consen   78 ECH-RHYHSMDVFAHYD   93 (205)
T ss_pred             chh-hhhhhhhcceeEE
Confidence            477 5999999887664


Done!